Retinoblastoma
101
16
24
40
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.9%
13 terminated out of 101 trials
75.5%
-11.0% vs benchmark
9%
9 trials in Phase 3/4
20%
8 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (101)
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Familial Investigations of Childhood Cancer Predisposition
Retinoblastoma Patient Clinical Database and Tissue Repository
Retinoblastoma Consolidation in Egyptians
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
Retinoblastoma Phase II Expanded Access Clinical Trial
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
Retinoblastoma Survivor Study: Assessment of General Health and Quality of Life
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)
Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?
GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
Cognitive Functioning and Health Related Quality of Life in Retinoblastoma Survivors
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
Conservative Treatments of Retinoblastoma
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Photoscreening for Retinoblastoma
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma